Literature DB >> 25804283

Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.

Paul E C Brenchley1.   

Abstract

Entities:  

Keywords:  anti-PLA2R; immunosuppression; membranous nephropathy; rituximab

Mesh：

Substances：

Year:  2015        PMID： 25804283      PMCID： PMC4587708          DOI： 10.1681/ASN.2015020181

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.

Authors:  Marieke J H Coenen; Julia M Hofstra; Hanna Debiec; Horia C Stanescu; Alan J Medlar; Bénédicte Stengel; Anne Boland-Augé; Johanne M Groothuismink; Detlef Bockenhauer; Steve H Powis; Peter W Mathieson; Paul E Brenchley; Robert Kleta; Jack F M Wetzels; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

3.  Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.

Authors:  Cornelia Dähnrich; Lars Komorowski; Christian Probst; Barbara Seitz-Polski; Vincent Esnault; Jack F Wetzels; Julia M Hofstra; Elion Hoxha; Rolf A Stahl; Gérard Lambeau; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Clin Chim Acta       Date:  2013-03-27       Impact factor: 3.786

4.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

5.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Laurence H Beck; David M Beck; Jack F Wetzels; David J Salant
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-07       Impact factor: 8.237

6.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.

Authors:  Barbora Svobodova; Eva Honsova; Pierre Ronco; Vladimir Tesar; Hanna Debiec
Journal:  Nephrol Dial Transplant       Date:  2012-12-06       Impact factor: 5.992

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.

Authors:  Gemma Bullich; José Ballarín; Artur Oliver; Nadia Ayasreh; Irene Silva; Sheila Santín; Montserrat M Díaz-Encarnación; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

9.  Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.

Authors:  Durga Kanigicherla; Jennet Gummadova; Edward A McKenzie; Stephen A Roberts; Shelley Harris; Milind Nikam; Kay Poulton; Lorna McWilliam; Colin D Short; Michael Venning; Paul E Brenchley
Journal:  Kidney Int       Date:  2013-01-30       Impact factor: 10.612

10.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Hanna Debiec; Colin D Short; Timotheé Pellé; Robert Kleta; Peter W Mathieson; Pierre Ronco; Paul E Brenchley; Jack F Wetzels
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121
View more
  3 in total

Review 1.  The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis.

Authors:  Wenli Wu; Jin Shang; Chenyang Tao; Shuai Wang; Xiaoru Hu; Shiyi Zhang; Zhanzheng Zhao
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

2.  Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.

Authors:  Christine Barrett; Lisa C Willcocks; Rachel B Jones; Ruth M Tarzi; Robert B Henderson; Gengqian Cai; Sophie I Gisbert; Alexandra S Belson; Caroline O Savage
Journal:  Nephrol Dial Transplant       Date:  2020-04-01       Impact factor: 5.992

3.  Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis.

Authors:  Weiying Li; Yuliang Zhao; Ping Fu
Journal:  Front Med (Lausanne)       Date:  2018-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.